TRAIL mediated signaling in human mast cells: The influence of IgE-dependent activation

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 63, Issue 3, 2008, Pages 333-340

  Berent Maoz, B ^a   Salemi, S ^b   Mankuta, D ^c   Simon, H U ^b   Levi Schaffer, F ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF BERN   (Switzerland)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Allergy; Apoptosis; Cell activation; IgE; Mast cells

Indexed keywords

IMMUNOGLOBULIN E; STEM CELL FACTOR;

ARTICLE; CELL CULTURE; HUMAN; IMMUNOBLOTTING; MAST CELL; MYELOID LEUKEMIA; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; UMBILICAL CORD BLOOD;

ANALYSIS OF VARIANCE; APOPTOSIS; CASPASE 3; CASPASE 8; CELLS, CULTURED; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN E; MAST CELLS; MITOCHONDRIA; PROBABILITY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UP-REGULATION;

EID: 38949199001     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2007.01598.x     Document Type: Article

References (37)

1. Padawer J. Mast cells: extended lifespan and lack of granule turnover under normal in vivo conditions. Exp Mol Pathol 1974 20 : 269 280.
2. Bischoff SC, Sellge G. Mast cell hyperplasia: role of cytokines. Int Arch Allergy Immunol 2002 127 : 118 122.
3. Mekori YA, Gilfillan AM, Akin C, Hartmann K, Metcalfe DD. Human mast cell apoptosis is regulated through Bcl-2 and Bcl-XL. J Clin Immunol 2001 21 : 171 174.
4. Baghestanian M, Jordan JH, Kiener HP, Bevec D, Agis H, Fritsch G et al. Activation of human mast cells through stem cell factor receptor (KIT) is associated with expression of bcl-2. Int Arch Allergy Immunol 2002 129 : 228 236.
5. Asai K, Kitaura J, Kawakami Y, Yamagata N, Tsai M, Carbone DP et al. Regulation of mast cell survival by IgE. Immunity 2001 14 : 791 800.
6. Kalesnikoff J, Huber M, Lam V, Damen JE, Zhang J, Siraganian RP et al. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 2001 14 : 801 811.
7. Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2002 2 : 773 786.
8. Kitaura J, Xiao W, Maeda-Yamamoto M, Kawakami Y, Lowell CA, Kawakami T. Early divergence of Fc epsilon receptor I signals for receptor up-regulation and internalization from degranulation, cytokine production, and survival. J Immunol 2004 173 : 4317 4323.
9. Berent-Maoz B, Piliponsky AM, Daigle I, Simon HU, Levi-Schaffer F. Human mast cells undergo TRAIL-induced apoptosis. J Immunol 2006 176 : 2272 2278.
10. Rudner J, Jendrossek V, Lauber K, Daniel PT, Wesselborg S, Belka C. TypeI and type II reactions in TRAIL-induced apoptosis - results from dose-response studies. Oncogene 2005 24 : 130 140.
11. Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, Kataoka T et al. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 1997 7 : 831 836.
12. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997 386 : 517 521.
13. Chawla-Sarkar M, Bae SI, Reu FJ, Jacobs BS, Lindner DJ, Borden EC. Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ 2004 11 : 915 923.
14. Han J, Goldstein LA, Gastman BR, Rabinowich H. Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis. J Biol Chem 2006 281 : 10153 10163.
15. Song JJ, An JY, Kwon YT, Lee YJ. Evidence for two modes of development of acquired tumor necrosis factor-related apoptosis-inducing ligand resistance. Involvement of Bcl-xL. J Biol Chem 2007 282 : 319 328.
16. Piliponsky AM, Gleich GJ, Nagler A, Bar I, Levi-Schaffer F. Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. Blood 2003 101 : 1898 1904.
17. Levi-Schaffer F, Shalit M. Proliferation and functional responses of bone marrow-derived mast cells after activation. Cell Immunol 1993 148 : 435 443.
18. Alfredsson J, Puthalakath H, Martin H, Strasser A, Nilsson G. Proapoptotic Bcl-2 family member Bim is involved in the control of mast cell survival and is induced together with Bcl-XL upon IgE-receptor activation. Cell Death Differ 2005 12 : 136 144.
19. Xiang Z, Ahmed AA, Moller C, Nakayama K, Hatakeyama S, Nilsson G. Essential role of the prosurvival bcl-2 homologue A1 in mast cell survival after allergic activation. J Exp Med 2001 194 : 1561 1569.
20. Dahl C, Saito H, Kruhoffer M, Schiotz PO. Identification of tryptase- and chymase-related gene clusters in human mast cells using microarrays. Allergy 2006 61 : 276 280.
21. Gulliksson M, Palmberg L, Nilsson G, Ahlstedt S, Kumlin M. Release of prostaglandin D2 and leukotriene C4 in response to hyperosmolar stimulation of mast cells. Allergy 2006 61 : 1473 1479.
22. Jenkins CE, Swiatoniowski A, Power MR, Lin TJ. Pseudomonas aeruginosa-induced human mast cell apoptosis is associated with up-regulation of endogenous Bcl-xS and down-regulation of Bcl-xL. J Immunol 2006 177 : 8000 8007.
23. Igarashi Y, Kurosawa M, Ishikawa O, Miyachi Y, Saito H, Ebisawa M et al. Characteristics of histamine release from cultured human mast cells. Clin Exp Allergy 1996 26 : 597 602.
24. Saito H, Ebisawa M, Tachimoto H, Shichijo M, Fukagawa K, Matsumoto K et al. Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J Immunol 1996 157 : 343 350.
25. Yamaguchi M, Sayama K, Yano K, Lantz CS, Noben-Trauth N, Ra C et al. IgE enhances Fc epsilon receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fc epsilon receptor I expression and mediator release. J Immunol 1999 162 : 5455 5465.
26. Mitsui H, Furitsu T, Dvorak AM, Irani AM, Schwartz LB, Inagaki N et al. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci USA 1993 90 : 735 739.
27. Zhao W, Oskeritzian CA, Pozez AL, Schwartz LB. Cytokine production by skin-derived mast cells: endogenous proteases are responsible for degradation of cytokines. J Immunol 2005 175 : 2635 2642.
28. Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2002 2 : 420 430.
29. Yoshikawa H, Nakajima Y, Tasaka K. Enhanced expression of Fas-associated death domain-like IL-1-converting enzyme (FLICE)-inhibitory protein induces resistance to Fas-mediated apoptosis in activated mast cells. J Immunol 2000 165 : 6262 6269.
30. Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell 2006 21 : 749 760.
31. Zhong Q, Gao W, Du F, Wang X. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 2005 121 : 1085 1095.
32. Zhao Y, Altman BJ, Coloff JL, Herman CE, Jacobs SR, Wieman HL et al. GSK-3{alpha}/{beta} mediate a glucose-sensitive anti-apoptotic signaling pathway to stabilize mcl-1. Mol Cell Biol 2007 27 : 4328 4339.
33. Alfredsson J, Moller C, Nilsson G. IgE-receptor activation of mast cells regulates phosphorylation and expression of forkhead and Bcl-2 family members. Scand J Immunol 2006 63 : 1 6.
34. Katoh N, Kraft S, Wessendorf JH, Bieber T. The high-affinity IgE receptor (FcepsilonRI) blocks apoptosis in normal human monocytes. J Clin Invest 2000 105 : 183 190.
35. Matsuda K, Piliponsky AM, Iikura M, Nakae S, Wang EW, Dutta SM et al. Monomeric IgE enhances human mast cell chemokine production: IL-4 augments and dexamethasone suppresses the response. J Allergy Clin Immunol 2005 116 : 1357 1363.
36. Robertson NM, Zangrilli JG, Steplewski A, Hastie A, Lindemeyer RG, Planeta MA et al. Differential expression of TRAIL and TRAIL receptors in allergic asthmatics following segmental antigen challenge: evidence for a role of TRAIL in eosinophil survival. J Immunol 2002 169 : 5986 5996.
37. Vassina E, Leverkus M, Yousefi S, Braathen LR, Simon HU, Simon D. Increased expression and a potential anti-inflammatory role of TRAIL in atopic dermatitis. J Invest Dermatol 2005 125 : 746 752.